ArriVent BioPharma Inc. (AVBP) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for ArriVent BioPharma Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$15.73
+2.14% today
Market cap
$759M
Overall quality
53/100
Kronos AI 30-day
+85.6%
8 of 8 simulated paths end higher
ArriVent BioPharma Inc. (AVBP) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $759M. It trades at $15.73, up 2.14% today. Its overall quality score is 53 out of 100, ranked against the whole US market. 12 analysts' average target of $25.55 implies +62.4% from today's price. Kronos AI's 30-day forecast is +85.6% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $25.55 |
| Low – high | $15.00 – $45.00 |
| Analysts | 12 |
| Upside to average | +62.4% |
Kronos AI 30-day forecast
| Expected close | $28.59 (+85.6%) |
| Likely range | +82.0% … +97.7% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 40 |
| Solvency | 90 |
| Growth | 28 |
| Overall | 53 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.